Skip to content
★ Sign in to follow
DV

Dame Vivienne Cox

Board Director
GlaxoSmithKline plc
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€20k
▼ Sales (0 ops.)
—

Latest filing published 24 Jun 2022 for GlaxoSmithKline plc, €9,832.

Filing timeline

BuySale
Dame Vivienne Cox

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Dame Vivienne Cox: trading record in brief

All filings by Dame Vivienne Cox on record concern GlaxoSmithKline plc. The record holds 2 filings, for trades running from 23 March 2022 to 23 June 2022.

Purchases make up the whole of the open-market record (2 purchases, €20k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

On 24 June 2022 came the latest disclosure, an open-market purchase for €9,832 in GlaxoSmithKline plc. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Dame Vivienne Cox

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    8,438 GBP0FCA-NSM
    498.965 shares@ £16.9149.2% of flowN/AISIN GB0009252882FCA-NSM:4417125-4
    Canonical exit: 21 Sept 2022 (T+90)
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    8,438 GBP0FCA-NSM
    530.704 shares@ £15.9050.8% of flowN/AISIN GB0009252882FCA-NSM:4313462-4
    Canonical exit: 21 Jun 2022 (T+90)

2 of 2 declarations